Journal of Cancer Research and Clinical Oncology

, Volume 131, Issue 9, pp 591–596 | Cite as

High expression of skp2 correlates with poor prognosis in endometrial endometrioid adenocarcinoma

  • Yuko Kamata
  • Jun Watanabe
  • Yukari Nishimura
  • Tsutomu Arai
  • Miwa Kawaguchi
  • Manabu Hattori
  • Akane Obokata
  • Hiroyuki Kuramoto
Original Paper
First Online:
Received:
Accepted:

Abstract

Purpose: Skp2 interacts with the degradation of cyclin-dependent kinase inhibitor p27. This study aimed to investigate the correlation of skp2 expression with the expression of p27 and other cell cycle regulators, and clinicopathological parameters in endometrial endometrioid adenocarcinoma. Methods: Tissue samples of 136 endometrioid adenocarcinomas, in addition to 20 endometrial hyperplasias and 20 normal endometria, were immunohistochemically stained for skp2. The expression was represented as a labeling index (LI), which indicates the percentage of positive nuclei. Results: Skp2 staining was localized in the nuclei of the glandular cells of the proliferative phase endometrium, and endometrial hyperplasia and carcinoma cells. Skp2 expression was increased significantly in those of higher histological grade. The high level of skp2 expression was significantly correlated with the presence of lymph node metastasis and lymph-vascular space involvement. The LI of skp2 in endometrial carcinoma was significantly correlated with that of p27, Ki-67, cdk2, cyclin A, cyclin D1, cyclin E, p53 and PTEN. The high level of skp2 expression (LI≧20%) was significantly correlated with the patients’ poor survival. Conclusions: The skp2 level might have increased due to p27 accumulation and may be a good indicator of proliferative activity and poor prognosis.

Keywords

skp2 p27 Cell cycle regulatory proteins Endometrial carcinoma 
This is a preview of subscription content, log in to check access.

Notes

Acknowledgements

This work supported by grants-in-aid for Project Research of the Graduate School of Medical Sciences, Kitasato University (Grants 2005 and 4007) and for Scientific Research from the Ministry of Education, Culture, Sports, Sciences and Technology (Grants 12670176 and 12671627), Japan.

References

  1. Ahn HJ, Kwon WK, Choi Y, Cho NH (1998) Expression of cyclin E and cyclin dependent kinase inhibitor, p27KIP in uterin endometrial carcinoma relationship with p53 status. Int J Surg Pathol 6:205–212CrossRefGoogle Scholar
  2. Akaboshi M, Watanabe J, Fujisawa T, Hattori M, Ohno E, Kuramoto H (2001) Immunohistochemical expression of cdk2 and Ki-67 in human endometrial carcinoma (in Japanese). J Jpn Soc Clin Cytol 40:121–127Google Scholar
  3. Anayama T, Furihata M, Ishikawa T, OhtsukiY, Ogoshi S (1998) Positive correlation between p27KIP1 expression and progression of human esophageal squamous cell carcinoma. Int J Cancer 79:439–443CrossRefPubMedGoogle Scholar
  4. Bamberger AM, Riethdorf L, Milde-Langosch K, Bamberger CM, Thuneke I, Erdmann I, Schulte HM, Loning T (1999) Strongly reduced expression of the cell cycle inhibitor p27 in endometrial neoplasia. Virchows Arch 434:423–428CrossRefPubMedGoogle Scholar
  5. Ben-Izhak O, Lahav-Baratz S, Meretyk S, Ben-Eliezer S, Sabo E, Dirnfeld M, Cohen S, Ciechanover A (2003) Inverse relationship between skp2 ubiquitin ligase and the cyclin dependent kinase inhibitor p27Kip1 in prostate cancer. J Urol 170:241–245CrossRefPubMedGoogle Scholar
  6. Bornstein G, Blooms J, Shevah DS, Nakayama K, Pagano M, Hershco A (2003) Role of the SCFSkp2 ubiquitin ligase in the degradation of p21Cip1 in S phase. J Biol Chem 278:25752–25757CrossRefPubMedGoogle Scholar
  7. Carrano AC, Eytan E, Hershko A, Pagano M (1999) SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat Cell Biol 1:193–199CrossRefPubMedGoogle Scholar
  8. Cheng JD, Werness BA, Babb JS, Meropol NJ (1999) Paradoxical correlations of cyclin-dependent kinase inhibitors p21waf1/cip1 and p27kip1 in metastatic colorectal carcinoma. Clin Cancer Res 5:1057–1062PubMedGoogle Scholar
  9. FIGO news (1989) Int J Gynecol Obstet 28:189–193CrossRefGoogle Scholar
  10. Fujisawa T, Watanabe J, Akaboshi M, Ohono E, Kuramoto H (2001) Immunohistochemical study on VEGF expression in endometrial carcinoma—comparison with p53 expression, angiogenesis, and tumor histologic grade. J Cancer Res Clin Oncol 127:668–674PubMedGoogle Scholar
  11. Ganoth D, Bornstein G, Ko TK, Larsen B, Tyers M, Pagano M, Hershko A (2001) The cell-cycle regulatory protein Cks1 is required for SCFSkp2 -mediated ubiqutinylation of p27. Nat Cell Biol 3:321–324CrossRefPubMedGoogle Scholar
  12. Gstaiger M, Jordan R, Lim M, Catzavelos C, Mestan J, Slongerland J, Krek W (2001) Skp2 is oncogenic and overexpressed in human cancers. PNAS 98:5043–5048CrossRefPubMedGoogle Scholar
  13. Hershko D, Bornstein G, Ben-Izhak O, Carrano A, Pagano M, Krausz MM, Hershco A (2001) Inverse relation between levels of p27Kip1 and of its ubiquitin ligase subunit skp2 in colorectal carcinoma. Cancer 91:1745–1751CrossRefPubMedGoogle Scholar
  14. Kato N, Watanabe J, Jobo T, Nishimura Y, Fujisawa T, Katmata Y, Kuramoto H (2003) Immunohistochemical expression of cyclin E in endometrial adenocarcinoma (endometrioid type) and its clinicopathological parameters. J Cancer Res Clin Oncol 129:222–226PubMedGoogle Scholar
  15. Kimura H, Watanabe J, Hata H, Fujisawa T, Kamata Y, Nishimura Y, Jobo T, Kuramoto H (2004) PTEN immunohistochemical expression is suppressed in G1 endometrioid adenocarcinoma of the uterine corpus. J Cancer Res Clin Oncol 130:161–168CrossRefPubMedGoogle Scholar
  16. Kudo Y, Kitajima S, Miyauchi M, Ogawa I, Takata T (2001) High expression of S-phase Kinase-interacting Protein 2, human F-box protein, correlates with poor prognosis in oral squamous cell carcinoma. Cancer Res 61:7044–7047PubMedGoogle Scholar
  17. Kyushima N, Watanabe J, IIata II, Jobo T, Kameya T, Kuramoto H (2002) Expression of cyclin A in endometrial adenocarcinoma and its correlation with proliferative activity and clinicopathological variables. J Cancer Res Clin Oncol 128:307–312CrossRefPubMedGoogle Scholar
  18. Lahav-Baratz S, Ben-Izhak O, Sabo E, Ben-Eliezer S, Lavie O, Ishai D, Ciechanover A, Dirnfeld M (2004) Decreased level of the cell cycle regulator p27 and increased level of its ubiquitin ligase skp2 in endometrial carcinoma but not in normal secretory or in hyperstimulated endometrium. Mol Hum Reprod 10:567–572CrossRefPubMedGoogle Scholar
  19. Loda M, Cukor B, Tam SW, Lavin P, Fiorentino M, Draetta GF, Jessup JM, Pagano M (1997) Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nat Med 3:231–234CrossRefPubMedGoogle Scholar
  20. Marti A, Wirbelauer C, Scheffnert M, Krek W (1999) Interaction between ubiquitination-protein ligase SCFskp2 and E2F-1 underlies the regulation of E2F-1 degradation. Nat Cell Biol 1:14–19CrossRefPubMedGoogle Scholar
  21. Nakayama K, Nagashima H, Minamishima YA, Matsumoto M (2000) Target disruption of skp2 results in accumulation of cyclin E and p27Kip1, polyploidy and centrosome overduplication. EMBO J 19:2069–2081CrossRefPubMedGoogle Scholar
  22. Nakayama K, Hatakeyama H, Nakayama K (2001) Regulation of the cell cycle at the G1-S transition by proteolysis of cyclin E and p27Kip1. Biochem Biophys Res Com 282:853–860CrossRefPubMedGoogle Scholar
  23. Nishimura Y, Watanabe J, Jobo T, Kato N, Fujisawa T, Kamata Y, Kuramoto H (2004) Cyclin D1 expression in endometrioid-type endometrial adenocarcinoma is correlated with histological grade and proliferative activity, but no with prognosis. Anticancer Res 24:2185–2192PubMedGoogle Scholar
  24. Schwartz AL, Ciechanover A (1999) The ubiquitin-proteasome pathway and pathogenesis of human diseases. Annu Rev Med 50:57–74CrossRefPubMedGoogle Scholar
  25. Shigemasa K, Gu L, O’Brien TJ, Ohama K (2003) Skp2 overexpression is a prognostic factor in patients with ovarian adenocarcinoma. Clin Cancer Res 9:1756–1763PubMedGoogle Scholar
  26. Signoretti S, Marcotullio LD, Richardson A, Ramaswamy S, Isaac B, Rue M, Monti F, Loda M, Pagano M (2002) Oncogenic role of the ubiquitin ligase subunit skp2 in human breast cancer. J Clin Invest 110:633–641CrossRefPubMedGoogle Scholar
  27. Singh SP, Lipman J, Goldman H, Ellis Jr FH, Aizenman L, Cangi MG, Signpretti S, Chiau DS, Pagano M, Loda M (1998) Loss or altered subcelluar localization of p27 in Barrett’s associated adenocarcinoma. Cancer Res 58:1730–1735PubMedGoogle Scholar
  28. Watanabe J, Sato H, Kanai T, Kamata Y, Jobo T, Hata H, Fujisawa T, Ohno E, Kuramoto H (2002) Paradoxical Expression of cell cycle inhibitor p27 in endometrioid adenocarcinoma of the uterine corpus—correlation with proliferation and clinicopathological parameters. Br J Cancer 87:81–85CrossRefPubMedGoogle Scholar
  29. Yang G, Ayala G, Marzo AD, Tian W, Frolov A, Thompson TC, Harper JW (2002) Elevated skp2 protein expression in human prostate cancer: association with loss of the cyclin-dependent kinase inhibitor p27 and PTEN and with reduced recurrence-free survival. Clin Cancer Res 8:3419–3426PubMedGoogle Scholar
  30. Yanping G, Geoffrey NS, Andrew B, Natasha K (1997) Loss of cyclin-dependent kinase inhibitor p27Kip1 protein in human prostate cancer correlates with tumor grade. Clin Cancer Res 3:2269–2274PubMedGoogle Scholar
  31. Zhang H, Kobayashi R, Galaktinov K, Beach D (1995) p19skp1 and p45skp2 are essential elements of the cyclin A-Cdk2 S phase kinase. Cell 82:915–925CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2005

Authors and Affiliations

  • Yuko Kamata
    • 1
  • Jun Watanabe
    • 2
  • Yukari Nishimura
    • 1
  • Tsutomu Arai
    • 1
  • Miwa Kawaguchi
    • 1
  • Manabu Hattori
    • 4
  • Akane Obokata
    • 1
  • Hiroyuki Kuramoto
    • 1
    • 3
    • 4
  1. 1.Department of Clinical Cytology, Graduate School of Medical SciencesKitasato UniversityKanagawaJapan
  2. 2.Department of Pathology, School of MedicineKitasato UniversityKanagawaJapan
  3. 3.Department of Obstetrics and Gynecology, School of MedicineKitasato UniversityKanagawaJapan
  4. 4.Department of Clinical Cytology, School of Allied Health SciencesKitasato UniversityKanagawaJapan

Personalised recommendations